Chemed Corporation CHE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.15% | 3.31% | 2.07% | 4.06% | 6.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.15% | 3.31% | 2.07% | 4.06% | 6.45% |
| Cost of Revenue | 4.13% | 3.97% | 5.72% | 8.05% | 10.87% |
| Gross Profit | 7.23% | 2.00% | -4.76% | -3.31% | -1.51% |
| SG&A Expenses | 6.70% | 6.30% | 2.21% | -1.08% | 0.18% |
| Depreciation & Amortization | 5.05% | 4.10% | 3.86% | 2.84% | 2.53% |
| Other Operating Expenses | 26.54% | -198.08% | -404.88% | -- | 88.12% |
| Total Operating Expenses | 4.65% | 4.42% | 4.96% | 6.03% | 8.48% |
| Operating Income | 8.23% | -3.12% | -13.53% | -6.83% | -4.49% |
| Income Before Tax | 3.20% | -4.84% | -15.03% | -10.94% | -6.20% |
| Income Tax Expenses | 9.02% | -3.52% | -12.51% | -7.11% | -1.67% |
| Earnings from Continuing Operations | 1.29% | -5.29% | -15.86% | -12.17% | -7.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.29% | -5.29% | -15.86% | -12.17% | -7.60% |
| EBIT | 8.23% | -3.12% | -13.53% | -6.83% | -4.49% |
| EBITDA | 7.83% | -2.08% | -11.21% | -5.48% | -3.47% |
| EPS Basic | 10.03% | 1.56% | -11.26% | -8.29% | -4.77% |
| Normalized Basic EPS | 14.92% | 4.26% | -8.27% | -6.04% | -4.26% |
| EPS Diluted | 10.48% | 2.32% | -10.65% | -7.77% | -4.42% |
| Normalized Diluted EPS | 15.44% | 5.08% | -7.60% | -5.47% | -3.87% |
| Average Basic Shares Outstanding | -7.80% | -6.52% | -4.94% | -4.15% | -3.12% |
| Average Diluted Shares Outstanding | -8.21% | -7.24% | -5.59% | -4.71% | -3.54% |
| Dividend Per Share | 19.05% | 20.00% | 21.05% | 22.22% | 23.53% |
| Payout Ratio | 0.09% | 0.19% | 0.36% | 0.33% | 0.30% |